Abstract
Background: Abnormal Glucose Tolerance (AGT), which encompasses diabetes and prediabetes, is a growing health problem globally. It is affecting millions and predisposing such patients to several complications, including ocular complications. Physical activity has been found to improve glycemic levels, but the specific effect on visual outcomes in a newly diagnosed African population with AGT is yet to be explored fully. This pilot randomized controlled trial seeks to evaluate the efficacy of a physical activity intervention among newly diagnosed persons with AGT in Cape Coast, Ghana.
Methods: An ostensibly healthy population will be screened for AGT. Persons newly diagnosed with AGT will be recruited into the randomized controlled trial. About 50 newly diagnosed participants with AGT will undergo a 12-week moderate-to-vigorous physical activity (MVPA) intervention, specifically exercises that burn more than 3.0 metabolic equivalents (METs), to ascertain its effect on their visual acuity, contrast sensitivity, central visual field and diabetic retinopathy status. The participants will be randomized into a physical activity intervention group and a control group. Assessments will be done at baseline, and treatment outcomes will be done on the last day of the intervention for each participant.
Discussion: Physical activity is a proven lifestyle intervention that reduces glycemic levels in people with AGT. Unfortunately, many persons are unaware of their high level of glucose tolerance, which is associated with the deterioration of vision. This study intends to investigate and present findings on the advantages of physical activity interventions on visual outcomes among people with AGT. The study holds promise in informing evidence-based interventions for persons with AGT in poor economies.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
PACTR202401462338744
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Cape Coast Institutional Review Board irb{at}ucc.edu.gh
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.
